pulmonary embolism/ccm board review
TRANSCRIPT
-
8/21/2019 Pulmonary Embolism/CCM Board review
1/46
!"#$%&'() +$,%#-.$
!"#$%&%" ($%#)* +,- ./+- 011!
2334&%"#) !$45)334$
,%6%3%47 45 !89:47"$; "7/ 1$%"3?%7@#47
-
8/21/2019 Pulmonary Embolism/CCM Board review
2/46
/-.0#%."(1
A ?"6) 74 B7"7&%"9 /%3&9438$)3C
-
8/21/2019 Pulmonary Embolism/CCM Board review
3/46
2,310451.
2D)$ #?%3 &48$3)- ;48 E%99 F) "F9) #4G
,)9%7)"#) #?) &4::47 H$)3)7
-
8/21/2019 Pulmonary Embolism/CCM Board review
4/46
6'.1 78
2 JK ;)"$ 49/ E4:"7 H$)3)7#3 #4 #?) ., E%#? "&8#)&?)3# H"%7 "7/ /;3H7)"C L?) "934 74#)3 9)D &"95 H"%7C
M)$ 479; H"3# :)/%&"9 ?%3#4$; %3 ?;H4#?;$4%/%3: "7/
?)$ :)/%&"
-
8/21/2019 Pulmonary Embolism/CCM Board review
5/46
9:-0: '.;10< %= :1( ;(1.1&
-
8/21/2019 Pulmonary Embolism/CCM Board review
6/46
@A@B@CD !E+F+ABCB@2A
-
8/21/2019 Pulmonary Embolism/CCM Board review
7/46
!(1.1&4&G F-G&. '&H F)$;
-
8/21/2019 Pulmonary Embolism/CCM Board review
8/46
J'. +K0:'&G1
]4# )6)$;47) %3 ?;H4I):%&!KPY E%#?!"RP^ ZX ::M@
+43# H)4H9) ?;H)$6)7
-
8/21/2019 Pulmonary Embolism/CCM Board review
9/46
+6J L-&H-&G.
S1 Q3 T3
Sinus tachycardia
RAD or RBBB
Giebel et al. Eur Respir J. 2005;25:843
-
8/21/2019 Pulmonary Embolism/CCM Board review
10/46
6:1.< E'H-%G(';: L-&H-&G.
Atelectasis 68%
Pleural effusion 32%
Pleural based opacity 21%
Westermarks sign 2%
Stein PD et al. Chest 1991; 100: 598
-
8/21/2019 Pulmonary Embolism/CCM Board review
11/46
6'.1 7M
2 KP ;)"$ 49/ `P!P- K E))*3 H43#NH"$#8:- H$)3)7#3E%#? /;3H7)" "7/ " 3E499)7 9)D 9)@C 2 1[ "7@%4@$":
$)6)"93 " H89:47"$; ):F49%3: "7/ 3?) %3 "/:%a)/ 54$
"7
-
8/21/2019 Pulmonary Embolism/CCM Board review
12/46
N-(0:%>
. B(-'H
b[.
L#"3%3
.7/4#?)9%"9A7g8$;
h14"@89"F%9%#;
-
8/21/2019 Pulmonary Embolism/CCM Board review
13/46
N-(0:%>
. B(-'H
b[.
A::4F%9%#;[$"6)9
L8$@)$;
1b1 %73#$8:)7#
+"9%@7"7&;!$%4$ b[.
-
8/21/2019 Pulmonary Embolism/CCM Board review
14/46
E-.O L'0
-
8/21/2019 Pulmonary Embolism/CCM Board review
15/46
/@CJA2F@F CA/ !E2JA2F@F
-
8/21/2019 Pulmonary Embolism/CCM Board review
16/46
!"#$%&'() C&G-%G(';:)
Renal failure
Hematoma
Arrhythmia
Death
Stein et al. Circulation1992;85:462
-
8/21/2019 Pulmonary Embolism/CCM Board review
17/46
-
8/21/2019 Pulmonary Embolism/CCM Board review
18/46
-
8/21/2019 Pulmonary Embolism/CCM Board review
19/46
-
8/21/2019 Pulmonary Embolism/CCM Board review
20/46
6B !"#$%&'() C&G-%G('$
!@2!+/ @@
6#-&-0'# !(%,',-#-
-
8/21/2019 Pulmonary Embolism/CCM Board review
21/46
6'.1 7Q
2 TP ;)"$ 49/ :"7 E%#? H$43#"#) &"7&)$ H$)3)7#3 E%#?
7)E 473)# /;3H7)" 47 )I)$
-
8/21/2019 Pulmonary Embolism/CCM Board review
22/46
P-. ;(1R
-
8/21/2019 Pulmonary Embolism/CCM Board review
23/46
91##. F0%(1
F-G&IF)$;
-
8/21/2019 Pulmonary Embolism/CCM Board review
24/46
/R/-$1(
L)73%
-
8/21/2019 Pulmonary Embolism/CCM Board review
25/46
-
8/21/2019 Pulmonary Embolism/CCM Board review
26/46
!(1H-0
-
8/21/2019 Pulmonary Embolism/CCM Board review
27/46
V1H.-H1 +0:%
-
8/21/2019 Pulmonary Embolism/CCM Board review
28/46
L-&H-&G. 6%&.-.-
-
8/21/2019 Pulmonary Embolism/CCM Board review
29/46
6'.1 7W
\J ;)"$ 49/ E4:"7 E%#?48# H"3# :)/%&"9 ?%3#4$; %3F$48@?# #4 #?) .:)$@)7&; ,)H"$#:)7# "D)$ &499"H3%7@
"# ?4:)C L?) %3 ?;H4#)73%6) "7/ ?;H4I):%&C 2
F)/3%/) )&?4&"$/%4@$": 3?4E3 " /%9"#)/- ?;H4*%7)
-
8/21/2019 Pulmonary Embolism/CCM Board review
30/46
X%"( -&%"#H ,1S
"U
A7#$"6)7483 ?)H"$%7 %7583%47 "947)
FU L8F&8#"7)483 94E :49)&89"$ E)%@?# ?)H"$%7 "947)
&U !9"&) "7 Ab1 B9#)$
/U
A7#$"6)7483 "9#)H9"3) k$#N!2U
)U L8$@%&"9 ):F49):;
-
8/21/2019 Pulmonary Embolism/CCM Board review
31/46
BE+CBT+AB
-
8/21/2019 Pulmonary Embolism/CCM Board review
32/46
P1$%H)&'$-0'##) Y&.
-
8/21/2019 Pulmonary Embolism/CCM Board review
33/46
P1$%H)&'$-0 F";;%()993
3&4$)c
"U m)3H%$"#4$; $"#) "7/ ?)"$# $"#)
FU
L%@73 45 ,b[- 4I;@)7"
-
8/21/2019 Pulmonary Embolism/CCM Board review
46/46
6'.1 7W
"U
[?)$) %3 )6%/)7&) #4 38HH4$# /)&$)"3)/ %7&%/)7&) 45$)&8$$)7# H89:47"$; ):F49%3:
FU [?)$) %3 )6%/)7&) #4 38HH4$# %:H$46)/ :4$#"9%#; %7
H"